Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Personalis, Inc. United States | 1 | 413 |
|
Tempus AI - RTP United States | 2 | 647 |
|
Tempus AI - CHI United States | 2 | 647 |
|
OnkoSight Advanced Breast Cancer Panel BioReference Health United States | 1 | 50 |
|
MayoComplete Solid Tumor Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 476 |
|
The Jackson Laboratory for Genomic Medicine United States | 1 | 517 |
|
PathGroup United States | 73 | 505 |
|
OmniSeq, Inc. United States | 1 | 525 |
|
GTC-Solid Tumor Profile Plus Fusion/Expression (DNA and RNA) Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Adenocarcinoma, colonic, somatic (RAD54L gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Providence St. Joseph Health Molecular Genomics Laboratory Providence St Joseph Health United States | 1 | 523 |
|
Prostate Cancer NGS panel (germeline analysis) CIBIC S.A. Argentina | 1 | 18 |
|
Prostate Cancer NGS panel (somatic analysis) CIBIC S.A. Argentina | 1 | 18 |
|
Hereditary Cancer Panel (Complete) Mendelics Brazil | 1 | 264 |
|
Mendelics Brazil | 1 | 40 |
|
OnkoSight Advanced Prostate NGS BioReference Health United States | 1 | 49 |
|
OnkoSight Advanced GYN Tumor NGS BioReference Health United States | 1 | 50 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.